The Royal College of Ophthalmologists recommendations on monitoring for hydroxychloroquine and chloroquine users in the United Kingdom (2020 revision): executive summary

The Royal College of Ophthalmologists recommendations on monitoring for hydroxychloroquine and chloroquine users in the United Kingdom (2020 revision): executive summary

Opis bibliograficzny
Główni autorzy:	Yusuf, IH, Foot, B, Lotery, AJ
Format:	Journal article
Język:	English
Wydane:	Springer Nature 2021

Podobne zapisy

The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary
od: Yusuf, IH, i wsp.
Wydane: (2018)

Joint recommendations for retinal screening in long‐term users of hydroxychloroquine and chloroquine in the United Kingdom, 2018
od: Yusuf, IH, i wsp.
Wydane: (2018)

Monitoring for retinal toxicity in patients taking hydroxychloroquine and chloroquine
od: Yusuf, IH, i wsp.
Wydane: (2018)

Baseline retinal testing is no longer recommended for hydroxychloroquine users in the United Kingdom
od: Yusuf, I, i wsp.
Wydane: (2021)

Requirement for retinal screening in patients taking hydroxychloroquine and chloroquine
od: Lotery, A, i wsp.
Wydane: (2018)

New recommendations for retinal monitoring in hydroxychloroquine users: Baseline testing is no longer supported
od: Yusuf, IH, i wsp.
Wydane: (2021)

Chloroquine, hydroxychloroquine and COVID-19
od: Erickson, T. B., i wsp.
Wydane: (2020)

Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine
od: David M. Stevens, i wsp.
Wydane: (2020-12-01)

Coding patterns used by ophthalmologists for hydroxychloroquine retinal toxicity
od: Chiu SY, i wsp.
Wydane: (2018-11-01)

The incidence, monitoring coverage and clinical characteristics of hydroxychloroquine retinopathy in the United Kingdom
od: Yusuf, IH, i wsp.
Wydane: (2024)

Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
od: Tzu-Chuan Ho, i wsp.
Wydane: (2021-02-01)

Chloroquine and Hydroxychloroquine in the Treatment of Dry Eye Disease
od: Julia Prinz, i wsp.
Wydane: (2023-06-01)

Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management
od: Jacob A. Lebin, i wsp.
Wydane: (2020-07-01)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
od: Javad Mahmoudi, i wsp.
Wydane: (2021-01-01)

The Ototoxicity of Chloroquine and Hydroxychloroquine: A Systematic Review
od: Carolina Pereira Fernandes, i wsp.
Wydane: (2022-01-01)

Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine
od: Vincent Gies, i wsp.
Wydane: (2020-07-01)

Off-Label Use of Chloroquine and Hydroxychloroquine for COVID-19 Treatment in Africa Against WHO Recommendation
od: Belayneh A
Wydane: (2020-09-01)

Chloroquine and Hydroxychloroquine: Potentially Inappropriate Medications for Older Adults?
od: Milton Gorzoni
Wydane: (2024-10-01)

Proarrhythmic effects of chloroquine and hydroxychloroquine in the context of Covid-19
od: Carlos Enrique Salgado-Fuentes
Wydane: (2021-05-01)

Prophylactic Effect of Chloroquine and Hydroxychloroquine on COVID-19 Treatment
od: Amin Ataie, i wsp.
Wydane: (2022-04-01)

Chloroquine or Hydroxychloroquine for COVID‐19: Is Cardiotoxicity a Concern?
od: Timothy J. Kamp, i wsp.
Wydane: (2020-06-01)

Chloroquine and Hydroxychloroquine Myopathy: Clinical Spectrum and Treatment Outcomes
od: Elie Naddaf, i wsp.
Wydane: (2021-02-01)

The mechanism of chloroquine/hydroxychloroquine and its application in stomatological diseases
od: LIN Lin, i wsp.
Wydane: (2021-03-01)

Rational use of chloroquine and hydroxychloroquine in times of COVID-19
od: Rosa Camila Lucchetta, i wsp.
Wydane: (2020-04-01)

Royal College recommendations to improve academic anesthesia in the United kingdom: how they compare with United States proposals.
od: Pandit, J
Wydane: (2006)

Elucidating the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Chloroquine and Hydroxychloroquine
od: Seidu A. Richard, i wsp.
Wydane: (2020-01-01)

Hydroxychloroquine and chloroquine for COVID-19 infection. Rapid systematic review
od: Rafael Leite Pacheco, i wsp.
Wydane: (2020-03-01)

Use of chloroquine and hydroxychloroquine in COVID-19 patients: A dilemma
od: Archana Bhatia, i wsp.
Wydane: (2022-01-01)

Narrative Review: Risk-Benefit Hydroxychloroquine and Chloroquine in COVID-19
od: Jarir At Thobari
Wydane: (2021-08-01)

Hydroxychloroquine and chloroquine in prophylaxis and treatment of COVID-19: What is known?
od: Pathiyil Ravi Shankar, i wsp.
Wydane: (2021-01-01)

The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19
od: Elangovan Manivannan, i wsp.
Wydane: (2021-05-01)

Repurposing Drugs for COVID-19: Pharmacokinetics and Pharmacogenomics of Chloroquine and Hydroxychloroquine
od: Babayeva M, i wsp.
Wydane: (2020-10-01)

Chloroquine and hydroxychloroquine binding to melanin: Some possible consequences for pathologies
od: R.L. Schroeder, i wsp.
Wydane: (2014-01-01)

Immunomodulatory effects of hydroxychloroquine and chloroquine in viral infections and their potential application in retinal gene therapy
od: Chandler, L, i wsp.
Wydane: (2020)

Thinking outside the circle—the potential value of ultra-widefield imaging
od: Yusuf, IH, i wsp.
Wydane: (2022)

Retinal Toxicity and the Use of Hydroxychloroquine and Chloroquine in the Current Management of COVID-19
od: Romulo N. Aguilar, MD, PhD, i wsp.
Wydane: (2020-06-01)

Early detection of the retinal bioelectrical dysfunction in patients treated by chloroquine/hydroxychloroquine
od: Wojciech Lubiński, i wsp.
Wydane: (2024-12-01)

Measuring the energy for the molecular graphs of antiviral agents: Hydroxychloroquine, Chloroquine and Remdesivir
od: Muhammad Haroon Aftab, i wsp.
Wydane: (2024-01-01)

Chloroquine/Hydroxychloroquine Use and Suicide Risk: Hypotheses for Confluent Etiopathogenetic Mechanisms?
od: Alessandra Costanza, i wsp.
Wydane: (2021-11-01)

Oxidative Stress, Proton Fluxes, and Chloroquine/Hydroxychloroquine Treatment for COVID-19
od: Christina B. Klouda, i wsp.
Wydane: (2020-09-01)